Skip to main content
Top
Published in: Diabetologia 3/2011

01-03-2011 | Article

Postprandial hyperaminoacidaemia overcomes insulin resistance of protein anabolism in men with type 2 diabetes

Authors: M. Bassil, E. B. Marliss, J. A. Morais, S. Pereira, S. Chevalier, R. Gougeon

Published in: Diabetologia | Issue 3/2011

Login to get access

Abstract

Aims/hypothesis

Although protein is usually ignored when considering insulin resistance, we have shown resistance of protein concurrent with glucose metabolism in men with type 2 diabetes during a hyperinsulinaemic clamp at euglycaemia and fasting aminoacidaemia. We hypothesised that this resistance is even worse during conditions that simulate the postprandial state, when anabolism should be maximal.

Methods

Eight overweight and obese men with type 2 diabetes underwent a hyperinsulinaemic–hyperglycaemic (8 mmol/l) clamp, first with plasma amino acids at postabsorptive (Hyper-2) then at postprandial concentrations (Hyper-3). Whole-body protein kinetics were assessed using l-[1-13C]leucine. Hyper-2 results were compared with those of diabetic men whose plasma glucose was lowered to 5.5 mmol/l and fasting aminoacidaemia maintained during the hyperinsulinaemic clamp (Hyper-1).

Results

In Hyper-2 vs Hyper-1 clamps, leucine flux (2.99 ± 0.16 vs 2.62 ± 0.06 μmol kg [fat-free mass (FFM)]−1 min−1), rates of synthesis (2.31 ± 0.15 vs 1.98 ± 0.06) and breakdown (2.38 ± 0.16 vs 2.00 ± 0.07) were higher (p < 0.05), but leucine oxidation and net balance did not differ. In Hyper-3 vs Hyper-2 clamps, leucine flux and synthesis and oxidation rates increased markedly as did net balance (0.84 ± 0.09 vs −0.07 ± 0.04 μmol [kg FFM]−1 min−1, p < 0.0001).

Conclusions/interpretation

In type 2 diabetic men, insulin resistance of protein metabolism is of the same magnitude at 8 vs 5.5 mmol/l, but turnover rates are higher with hyperglycaemia. Contrary to our hypothesis, sustained postprandial-level hyperaminoacidaemia stimulated positive net protein balance comparable with that previously found in lean non-diabetic men. This was sufficient to overcome the insulin resistance of protein anabolism.
Literature
1.
go back to reference Pereira S, Marliss EB, Morais JA, Chevalier S, Gougeon R (2008) Insulin resistance of protein metabolism in type 2 diabetes. Diabetes 57:56–63CrossRefPubMed Pereira S, Marliss EB, Morais JA, Chevalier S, Gougeon R (2008) Insulin resistance of protein metabolism in type 2 diabetes. Diabetes 57:56–63CrossRefPubMed
2.
go back to reference Park SW, Goodpaster BH, Lee JS et al (2009) Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care 32:1993–1997CrossRefPubMed Park SW, Goodpaster BH, Lee JS et al (2009) Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care 32:1993–1997CrossRefPubMed
3.
go back to reference Kim TN, Park MS, Yang SJ et al (2010) Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: The Korean Sarcopenic Obesity Study (KSOS). Diabetes Care 33:1497–1499CrossRefPubMed Kim TN, Park MS, Yang SJ et al (2010) Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: The Korean Sarcopenic Obesity Study (KSOS). Diabetes Care 33:1497–1499CrossRefPubMed
4.
go back to reference Jefferson LS, Koehler JO, Morgan HE (1972) Effect of insulin on protein synthesis in skeletal muscle of an isolated perfused preparation of rat hemicorpus. Proc Natl Acad Sci USA 69:816–820CrossRefPubMed Jefferson LS, Koehler JO, Morgan HE (1972) Effect of insulin on protein synthesis in skeletal muscle of an isolated perfused preparation of rat hemicorpus. Proc Natl Acad Sci USA 69:816–820CrossRefPubMed
5.
go back to reference Nakano K, Hara H (1979) Insulin dependent and independent actions of dietary protein on in vitro protein synthesis in skeletal muscle of rats. J Nutr 109:1390–1398PubMed Nakano K, Hara H (1979) Insulin dependent and independent actions of dietary protein on in vitro protein synthesis in skeletal muscle of rats. J Nutr 109:1390–1398PubMed
6.
go back to reference Tessari P (1994) Effects of insulin on whole-body and regional amino acid metabolism. Diabetes Metab Rev 10:253–285CrossRefPubMed Tessari P (1994) Effects of insulin on whole-body and regional amino acid metabolism. Diabetes Metab Rev 10:253–285CrossRefPubMed
7.
go back to reference Tischler ME, Desautels M, Goldberg AL (1982) Does leucine, leucyl-tRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle? J Biol Chem 257:1613–1621PubMed Tischler ME, Desautels M, Goldberg AL (1982) Does leucine, leucyl-tRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle? J Biol Chem 257:1613–1621PubMed
8.
go back to reference Adegoke OAJ, Chevalier S, Morais JA et al (2009) Fed-state clamp stimulates cellular mechanisms of muscle protein anabolism and modulates glucose disposal in normal men. Am J Physiol Endocrinol Metab 296:E105–E113CrossRefPubMed Adegoke OAJ, Chevalier S, Morais JA et al (2009) Fed-state clamp stimulates cellular mechanisms of muscle protein anabolism and modulates glucose disposal in normal men. Am J Physiol Endocrinol Metab 296:E105–E113CrossRefPubMed
9.
go back to reference Bennet WM, Connacher AA, Scrimgeour CM, Jung RT, Rennie MJ (1990) Euglycemic hyperinsulinemia augments amino acid uptake by human leg tissues during hyperaminoacidemia. Am J Physiol Endocrinol Metab 259:E185–E194 Bennet WM, Connacher AA, Scrimgeour CM, Jung RT, Rennie MJ (1990) Euglycemic hyperinsulinemia augments amino acid uptake by human leg tissues during hyperaminoacidemia. Am J Physiol Endocrinol Metab 259:E185–E194
10.
go back to reference Hillier TA, Fryburg DA, Jahn LA, Barrett EJ (1998) Extreme hyperinsulinemia unmasks insulin's effect to stimulate protein synthesis in the human forearm. Am J Physiol Endocrinol Metab 274:E1067–E1074 Hillier TA, Fryburg DA, Jahn LA, Barrett EJ (1998) Extreme hyperinsulinemia unmasks insulin's effect to stimulate protein synthesis in the human forearm. Am J Physiol Endocrinol Metab 274:E1067–E1074
11.
go back to reference Castellino P, Luzi L, Simonson DC, Haymond M, DeFronzo RA (1987) Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesis. J Clin Invest 80:1784–1793CrossRefPubMed Castellino P, Luzi L, Simonson DC, Haymond M, DeFronzo RA (1987) Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesis. J Clin Invest 80:1784–1793CrossRefPubMed
12.
go back to reference Tessari P, Inchiostro S, Biolo G et al (1987) Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo. Evidence for distinct mechanisms in regulation of net amino acid deposition. J Clin Invest 79:1062–1069CrossRefPubMed Tessari P, Inchiostro S, Biolo G et al (1987) Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo. Evidence for distinct mechanisms in regulation of net amino acid deposition. J Clin Invest 79:1062–1069CrossRefPubMed
13.
go back to reference Nygren J, Nair KS (2003) Differential regulation of protein dynamics in splanchnic and skeletal muscle beds by insulin and amino acids in healthy human subjects. Diabetes 52:1377–1385CrossRefPubMed Nygren J, Nair KS (2003) Differential regulation of protein dynamics in splanchnic and skeletal muscle beds by insulin and amino acids in healthy human subjects. Diabetes 52:1377–1385CrossRefPubMed
14.
go back to reference Chevalier S, Marliss EB, Morais JA, Lamarche M, Gougeon R (2005) Whole-body protein anabolic response is resistant to the action of insulin in obese women. Am J Clin Nutr 82:355–365PubMed Chevalier S, Marliss EB, Morais JA, Lamarche M, Gougeon R (2005) Whole-body protein anabolic response is resistant to the action of insulin in obese women. Am J Clin Nutr 82:355–365PubMed
15.
go back to reference Denne SC, Brechtel G, Johnson A, Liechty EA, Baron AD (1995) Skeletal muscle proteolysis is reduced in noninsulin-dependent diabetes mellitus and is unaltered by euglycemic hyperinsulinemia or intensive insulin therapy. J Clin Endocrinol Metab 80:2371–2377CrossRefPubMed Denne SC, Brechtel G, Johnson A, Liechty EA, Baron AD (1995) Skeletal muscle proteolysis is reduced in noninsulin-dependent diabetes mellitus and is unaltered by euglycemic hyperinsulinemia or intensive insulin therapy. J Clin Endocrinol Metab 80:2371–2377CrossRefPubMed
16.
go back to reference Halvatsiotis PG, Turk D, Alzaid A, Dinneen S, Rizza RA, Nair KS (2002) Insulin effect on leucine kinetics in type 2 diabetes mellitus. Diabetes Nutr Metab 15:136–142PubMed Halvatsiotis PG, Turk D, Alzaid A, Dinneen S, Rizza RA, Nair KS (2002) Insulin effect on leucine kinetics in type 2 diabetes mellitus. Diabetes Nutr Metab 15:136–142PubMed
17.
go back to reference Luzi L, Petrides AS, de Fronzo RA (1993) Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM. Diabetes 42:1868–1877CrossRefPubMed Luzi L, Petrides AS, de Fronzo RA (1993) Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM. Diabetes 42:1868–1877CrossRefPubMed
18.
go back to reference Manders RJ, Koopman R, Beelen M et al (2008) The muscle protein synthetic response to carbohydrate and protein ingestion is not impaired in men with longstanding type 2 diabetes. J Nutr 138:1079–1085PubMed Manders RJ, Koopman R, Beelen M et al (2008) The muscle protein synthetic response to carbohydrate and protein ingestion is not impaired in men with longstanding type 2 diabetes. J Nutr 138:1079–1085PubMed
19.
go back to reference Bassil M, Marliss EB, Morais JA, Gougeon R (2009) Net protein anabolic response is not altered during hyperaminoacidemic (hyperAA) clamp in men with Type 2 Diabetes (T2D). FASEB J 23:1CrossRef Bassil M, Marliss EB, Morais JA, Gougeon R (2009) Net protein anabolic response is not altered during hyperaminoacidemic (hyperAA) clamp in men with Type 2 Diabetes (T2D). FASEB J 23:1CrossRef
20.
go back to reference (1997) The MONICA Optional Study of Physical Activity (MOSPA). Med Sci Sports Exerc 29:162–169 (1997) The MONICA Optional Study of Physical Activity (MOSPA). Med Sci Sports Exerc 29:162169
21.
go back to reference Zello GA, Smith JM, Pencharz PB, Oball R (1990) Development of a heating device for sampling arterialized venous blood from a hand vein. Ann Clin Biochem 27:366–372PubMed Zello GA, Smith JM, Pencharz PB, Oball R (1990) Development of a heating device for sampling arterialized venous blood from a hand vein. Ann Clin Biochem 27:366–372PubMed
22.
go back to reference Nuttall FQ, Gannon MC (1991) Plasma glucose and insulin response to macronutrients in nondiabetic and NIDDM subjects. Diabetes Care 14:824–838CrossRefPubMed Nuttall FQ, Gannon MC (1991) Plasma glucose and insulin response to macronutrients in nondiabetic and NIDDM subjects. Diabetes Care 14:824–838CrossRefPubMed
23.
go back to reference Matthews DE, Motil KJ, Rohrbaugh DK, Burke JF, Young VR, Bier DM (1980) Measurement of leucine metabolism in man from a primed, continuous infusion of L-[1-13C]leucine. Am J Physiol 238:E473–E479PubMed Matthews DE, Motil KJ, Rohrbaugh DK, Burke JF, Young VR, Bier DM (1980) Measurement of leucine metabolism in man from a primed, continuous infusion of L-[1-13C]leucine. Am J Physiol 238:E473–E479PubMed
24.
go back to reference Matthews DE, Schwarz HP, Yang RD, Motil KJ, Young VR, Bier DM (1982) Relationship of plasma leucine and alpha-ketoisocaproate during a L-[1-13C]leucine infusion in man: a method for measuring human intracellular leucine tracer enrichment. Metabolism 31:1105–1112CrossRefPubMed Matthews DE, Schwarz HP, Yang RD, Motil KJ, Young VR, Bier DM (1982) Relationship of plasma leucine and alpha-ketoisocaproate during a L-[1-13C]leucine infusion in man: a method for measuring human intracellular leucine tracer enrichment. Metabolism 31:1105–1112CrossRefPubMed
25.
go back to reference Cynober LA (ed) (1995) Amino acid metabolism and therapy in health and nutritional disease. CRC Press, Boca Raton Cynober LA (ed) (1995) Amino acid metabolism and therapy in health and nutritional disease. CRC Press, Boca Raton
26.
go back to reference Chevalier S, Gougeon R, Kreisman SH, Cassis C, Morais JA (2004) The hyperinsulinemic amino acid clamp increases whole-body protein synthesis in young subjects. Metabolism 53:388–396CrossRefPubMed Chevalier S, Gougeon R, Kreisman SH, Cassis C, Morais JA (2004) The hyperinsulinemic amino acid clamp increases whole-body protein synthesis in young subjects. Metabolism 53:388–396CrossRefPubMed
27.
go back to reference Chevalier S, Marliss EB, Morais JA, Lamarche M, Gougeon R (2005) The influence of sex on the protein anabolic response to insulin. Metabolism 54:1529–1535CrossRefPubMed Chevalier S, Marliss EB, Morais JA, Lamarche M, Gougeon R (2005) The influence of sex on the protein anabolic response to insulin. Metabolism 54:1529–1535CrossRefPubMed
28.
go back to reference Chevalier S, Burgess SC, Malloy CR, Gougeon R, Marliss EB, Morais JA (2006) The greater contribution of gluconeogenesis to glucose production in obesity is related to increased whole-body protein catabolism. Diabetes 55:675–681CrossRefPubMed Chevalier S, Burgess SC, Malloy CR, Gougeon R, Marliss EB, Morais JA (2006) The greater contribution of gluconeogenesis to glucose production in obesity is related to increased whole-body protein catabolism. Diabetes 55:675–681CrossRefPubMed
29.
go back to reference Lachin JM (1981) Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials 2:93–113CrossRefPubMed Lachin JM (1981) Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials 2:93–113CrossRefPubMed
30.
go back to reference World Health Organization (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. The Organization, Geneva World Health Organization (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. The Organization, Geneva
31.
go back to reference Manders RJF, Wagenmakers AJM, Koopman R et al (2005) Co-ingestion of a protein hydrolysate and amino acid mixture with carbohydrate improves plasma glucose disposal in patients with type 2 diabetes. Am J Clin Nutr 82:76–83PubMed Manders RJF, Wagenmakers AJM, Koopman R et al (2005) Co-ingestion of a protein hydrolysate and amino acid mixture with carbohydrate improves plasma glucose disposal in patients with type 2 diabetes. Am J Clin Nutr 82:76–83PubMed
32.
go back to reference Lan-Pidhainy X, Wolever TM (2010) The hypoglycemic effect of fat and protein is not attenuated by insulin resistance. Am J Clin Nutr 91:98–105CrossRefPubMed Lan-Pidhainy X, Wolever TM (2010) The hypoglycemic effect of fat and protein is not attenuated by insulin resistance. Am J Clin Nutr 91:98–105CrossRefPubMed
33.
go back to reference Gougeon R (2001) Effect of insulin and energy restriction on the thermic effect of protein in type 2 diabetes mellitus. Obes Res 9:241–250CrossRefPubMed Gougeon R (2001) Effect of insulin and energy restriction on the thermic effect of protein in type 2 diabetes mellitus. Obes Res 9:241–250CrossRefPubMed
34.
go back to reference Mourad C, Chevalier S, Morais JA, Lamarche M, Gougeon R (2009) Antihyperglycaemic medication modifies factors of postprandial satiety in type 2 diabetes. Diabetes Obes Metab 11:819–822CrossRefPubMed Mourad C, Chevalier S, Morais JA, Lamarche M, Gougeon R (2009) Antihyperglycaemic medication modifies factors of postprandial satiety in type 2 diabetes. Diabetes Obes Metab 11:819–822CrossRefPubMed
35.
go back to reference Volpi E, Mittendorfer B, Rasmussen BB, Wolfe RR (2000) The response of muscle protein anabolism to combined hyperaminoacidemia and glucose-induced hyperinsulinemia is impaired in the elderly. J Clin Endocrinol Metab 85:4481–4490CrossRefPubMed Volpi E, Mittendorfer B, Rasmussen BB, Wolfe RR (2000) The response of muscle protein anabolism to combined hyperaminoacidemia and glucose-induced hyperinsulinemia is impaired in the elderly. J Clin Endocrinol Metab 85:4481–4490CrossRefPubMed
36.
go back to reference Volpi E, Ferrando AA, Yeckel CW, Tipton KD, Wolfe RR (1998) Exogenous amino acids stimulate net muscle protein synthesis in the elderly. J Clin Invest 101:2000–2007CrossRefPubMed Volpi E, Ferrando AA, Yeckel CW, Tipton KD, Wolfe RR (1998) Exogenous amino acids stimulate net muscle protein synthesis in the elderly. J Clin Invest 101:2000–2007CrossRefPubMed
37.
go back to reference Buse MG, Reid SS (1975) Leucine. A possible regulator of protein turnover in muscle. J Clin Invest 56:1250–1261CrossRefPubMed Buse MG, Reid SS (1975) Leucine. A possible regulator of protein turnover in muscle. J Clin Invest 56:1250–1261CrossRefPubMed
38.
go back to reference Anthony JC, Anthony TG, Layman DK (1999) Leucine supplementation enhances skeletal muscle recovery in rats following exercise. J Nutr 129:1102–1106PubMed Anthony JC, Anthony TG, Layman DK (1999) Leucine supplementation enhances skeletal muscle recovery in rats following exercise. J Nutr 129:1102–1106PubMed
39.
go back to reference Kim D-H, Sarbassov DD, Ali SM et al (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110:163–175CrossRefPubMed Kim D-H, Sarbassov DD, Ali SM et al (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110:163–175CrossRefPubMed
40.
go back to reference Kimball SR, Shantz LM, Horetsky RL, Jefferson LS (1999) Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6. J Biol Chem 274:11647–11652CrossRefPubMed Kimball SR, Shantz LM, Horetsky RL, Jefferson LS (1999) Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6. J Biol Chem 274:11647–11652CrossRefPubMed
41.
go back to reference Sancak Y, Peterson TR, Shaul YD et al (2008) The rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320:1496–1501CrossRefPubMed Sancak Y, Peterson TR, Shaul YD et al (2008) The rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320:1496–1501CrossRefPubMed
42.
go back to reference Flakoll PJ, Hill JO, Abumrad NN (1993) Acute hyperglycemia enhances proteolysis in normal man. Am J Physiol 265:E715–E721PubMed Flakoll PJ, Hill JO, Abumrad NN (1993) Acute hyperglycemia enhances proteolysis in normal man. Am J Physiol 265:E715–E721PubMed
43.
go back to reference Gougeon R, Styhler K, Morais JA, Jones PJ, Marliss EB (2000) Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes. Diabetes Care 23:1–8CrossRefPubMed Gougeon R, Styhler K, Morais JA, Jones PJ, Marliss EB (2000) Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes. Diabetes Care 23:1–8CrossRefPubMed
44.
go back to reference Gougeon R, Pencharz PB, Sigal RJ (1997) Effect of glycemic control on the kinetics of whole-body protein metabolism in obese subjects with non-insulin-dependent diabetes mellitus during iso- and hypoenergetic feeding. Am J Clin Nutr 65:861–870PubMed Gougeon R, Pencharz PB, Sigal RJ (1997) Effect of glycemic control on the kinetics of whole-body protein metabolism in obese subjects with non-insulin-dependent diabetes mellitus during iso- and hypoenergetic feeding. Am J Clin Nutr 65:861–870PubMed
45.
go back to reference Gougeon R, Pencharz PB, Marliss EB (1994) Effect of NIDDM on the kinetics of whole-body protein metabolism. Diabetes 43:318–328CrossRefPubMed Gougeon R, Pencharz PB, Marliss EB (1994) Effect of NIDDM on the kinetics of whole-body protein metabolism. Diabetes 43:318–328CrossRefPubMed
46.
go back to reference Gougeon R, Morais JA, Pencharz PB, Jones PJ, Marliss E (1997) Oral agents and insulin improve the abnormalities in protein turnover in proportion to glycemic improvement in obese type 2 diabetic subjects. Int J Obes (Suppl 2):S108 Gougeon R, Morais JA, Pencharz PB, Jones PJ, Marliss E (1997) Oral agents and insulin improve the abnormalities in protein turnover in proportion to glycemic improvement in obese type 2 diabetic subjects. Int J Obes (Suppl 2):S108
47.
go back to reference Luzi L, Castellino P, DeFronzo RA (1996) Insulin and hyperaminoacidemia regulate by a different mechanism leucine turnover and oxidation in obesity. Am J Physiol 270:E273–E281PubMed Luzi L, Castellino P, DeFronzo RA (1996) Insulin and hyperaminoacidemia regulate by a different mechanism leucine turnover and oxidation in obesity. Am J Physiol 270:E273–E281PubMed
48.
go back to reference Wolfe R (1992) Radioactive and stable isotope tracers in biomedicine. Wiley, New York Wolfe R (1992) Radioactive and stable isotope tracers in biomedicine. Wiley, New York
Metadata
Title
Postprandial hyperaminoacidaemia overcomes insulin resistance of protein anabolism in men with type 2 diabetes
Authors
M. Bassil
E. B. Marliss
J. A. Morais
S. Pereira
S. Chevalier
R. Gougeon
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 3/2011
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-010-1980-9

Other articles of this Issue 3/2011

Diabetologia 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.